T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

These high-quality solutions encompass reagents for T cell culturing, activation, and engineering, CMC process purification, and residue detection. They are designed to support innovation, grow ...

A recently developed cancer treatment called chimeric antigen receptor T-cell therapy (CAR T-cell therapy, for short) offers hope to people whose diffuse large B-cell lymphoma (DLBCL) has proved ...

USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

But before they can mount an effective response, the rare T-cells with the right specificity must undergo a process of activation, expansion, and specialization. This process—known as T-cell ...

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen ...

Despite the massive successes of immunotherapy, which utilizes the body's immune system as a tool to fight cancer, therapy resistance is still a common treatment obstacle for many patients with solid ...